| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, CMO, Head-res&Drug | CMO,SVP,Head-res&Drug | CMO, SVP &Head Of Drug Devt.
1 company
Shetzline Michael is a SVP, CMO, Head-res&Drug at IRWD. Recent filings cover 0 purchases and 21 sales.
Our model assigns Shetzline Michael a middling insider score of 67/100, based on 10 past trades. Over a 12-month horizon, 60.0% of those trades were profitable, with an average 12-month return of +5.6%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | IRWD Ironwood Pharmaceuticals, Inc. | SVP, CMO, Head-res&Drug | Sell | 32,582 | $3.73 | $121,585.62 | -3.0% | +2.9% | - | |
| Feb 10, 2025 | IRWD Ironwood Pharmaceuticals Inc | SVP, CMO, Head-res&Drug | Sell | 41,269 | $1.76 | $72,633.44 | -6.9% | -58.5% | +159.3% | |
| May 20, 2024 | IRWD Ironwood Pharmaceuticals Inc | CMO,SVP,Head-res&Drug | Sell | 16,128 | $6.45 | $104,025.60 | -3.8% | -25.9% | -89.8% | |
| Feb 12, 2024 | IRWD Ironwood Pharmaceuticals Inc | CMO,SVP,Head-res&Drug | Sell | 38,618 | $15.24 | $588,538.32 | -10.2% | -56.5% | -87.8% | |
| May 22, 2023 | IRWD Ironwood Pharmaceuticals Inc | CMO,SVP,Head-res&Drug | Sell | 10,324 | $10.12 | $104,478.88 | -3.1% | -10.4% | -37.5% | |
| Feb 28, 2023 | IRWD Ironwood Pharmaceuticals Inc | CMO,SVP,Head-res&Drug | Sell | 19,322 | $11.36 | $219,478.62 | -6.9% | -4.6% | +34.2% | |
| May 23, 2022 | IRWD Ironwood Pharmaceuticals Inc | CMO,SVP,Head-res&Drug | Sell | 10,583 | $11.50 | $121,704.50 | -3.8% | +1.7% | -3.5% | |
| Feb 28, 2022 | IRWD Ironwood Pharmaceuticals Inc | CMO,SVP,Head-res&Drug | Sell | 17,607 | $10.77 | $189,627.39 | -8.3% | +4.7% | +4.7% | |
| Nov 23, 2021 | IRWD Ironwood Pharmaceuticals Inc | CMO,SVP,Head-res&Drug | Sell | 13,776 | $11.58 | $159,526.08 | -7.0% | -6.5% | -0.4% | |
| May 24, 2021 | IRWD Ironwood Pharmaceuticals Inc | CMO, SVP &Head Of Drug Devt. | Sell | 2,077 | $12.25 | $25,443.25 | -1.0% | +7.0% | -9.6% |